We are indeed fortunate
to be partnered with such high quality CMOs that have a deep experience with antisense drugs and
both of which we have been working with for over 15 years and that can support manufacture all the
way through to commercial sale of product”
Ann: Manufacture of ATL1102 clinical supplies for Phase IIb trial, page-2
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.7¢ |
Change
0.004(5.48%) |
Mkt cap ! $69.41M | |||
| Open | High | Low | Value | Volume |
| 7.3¢ | 7.7¢ | 7.3¢ | $40.33K | 536.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 7.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.7¢ | 79999 | 1 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.6¢ |
Change
0.004 ( 5.56 %) |
||||
| Open | High | Low | Volume | ||
| 7.5¢ | 7.6¢ | 7.4¢ | 32400 | ||
| Last updated 14.37pm 02/05/2024 ? | |||||
| PER (ASX) Chart |